Benefits
75 articles
Medical Marijuana: More Science Could Help Clear the Air
What’s the scoop on medical marijuana? Legal? Helpful? Find the most up-to-date information on what it is approved for, and where the research is going.
Laboratory Study Shows Keto Diet May Enhance Chemotherapy
Dr. Joshua Rabinowitz’s initial study has found that a Keto diet may enhance the effects of chemotherapy and treatment for pancreatic cancer.
2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Ablative SMART Radiotherapy Could Be Beneficial for Advanced Pancreatic Cancer
Learn the advantages of radiation treatment for pancreatic cancer with an MRI-guided system as researched by radiation oncologist Dr. Michael Chuong.
New Study to Get More Minorities Involved in Genetic Testing
Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Improving Access to Genetic Testing and Counseling
Dr. Angela Bradbury is leading a study on access to genetic testing and genetic counseling, including a telehealth option.
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
GENERATE Trial Expands Eligibility
Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.
Combination Delivers a Dual Punch to Pancreatic Cell Growth
Dr. Conan Kinsey outlines a clinical trial that has moved quickly from the lab to phase I, with a dual approach to delivering pancreatic cancer treatment.
Research and Other Highlights from the 2023 AACR Annual Meeting
The 2023 AACR meeting focused on the latest research into KRAS, other immunotherapy approaches, and honored Dr. Elizabeth Jaffee.
Early Study Shows Exercise Alone Can Reduce Inflammation
Dr. Zobeida Cruz-Monserrate is studying how exercise can reduce inflammation, and how that impacts pancreatic cancer.
Chemo Before Surgery Doubles Overall Survival in Some Patients
Dr. Marco Del Chiaro explains the results of an international study of outcomes for patients who had neoadjuvant treatment before surgery.